Vitamin B2, also known as riboflavin, has been studied in the context of preventing or alleviating migraines in several medical research studies. According to the available research data, there is evidence to suggest that Vitamin B2 may be beneficial in the management of migraines. In a review published in the journal Headache in 2017, it was concluded that supplementation with high-dose riboflavin can reduce the frequency and intensity of migraines. This finding is supported by some clinical trials showing positive outcomes with riboflavin supplementation.
Further research conducted more recently also supports the potential benefits of Vitamin B2 in Migraine management. A randomized controlled trial published in the European Journal of Neurology in 2020 found that riboflavin supplementation significantly reduced the number of headache days and the duration of attacks in patients with episodic Migraine The study recommended riboflavin as a safe and effective treatment option, particularly for those who prefer to avoid pharmaceutical interventions.
